The global molecular biology enzymes, reagents, and kits market size is expected to reach USD 34.11 billion by 2033, registering a CAGR of 9.99% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growth of the market globally can be attributed to continuous advancement in technologies in the molecular biology field, the prevalence of infectious and chronic diseases, increased usage of sequencing technologies and growing omics-based research activities.
The COVID-19 pandemic exponentially increased the demand for molecular biology enzymes, reagents, and kits, and the continuous rise in cases worldwide kept the demand on the higher side. Many market players, healthcare organizations, and academic and research institutes were actively engaged in the development of vaccines and they increased the research for repurposing the existing therapeutics for the treatment of COVID-19 infection. This continuous R&D activity is expected to boost the demand for these products in the coming years. Moreover, in an effort to detect the SARS-CoV-2 virus faster, many new products were launched by the key market players, such as RNA extraction kits. For example, in June 2020, Omega Bio-tek, Inc. announced the launch of its “Mag-Bind Viral RNA Xpress Kit” for RNA isolation in a reliable and rapid manner from the nasopharyngeal swab of patient samples.
Continuous funding and investments in the field of synthetic biology and multi-omics are expanding the field of biotechnology. As per a press release in March 2022, The Bristol Centre for Engineering Biology, BrisEngBio, is an institute that supports research and discovery in synthetic biology. It is a UKRI-funded research center that has published over 325 research papers, collaborated with 8 biotech companies, and received an additional USD 117.90 million for research. This rapidly advancing field of synthetic biology and multi-omics will result in more extensive adoption of molecular biology, enzymes, kits, and reagent products, which serve as educational tools. And this adoption rate further enhances the development of innovative methods such as drug discovery, diagnostics development, and gene therapies manufacturing, hence driving the market significantly.
The key market players are expanding their global presence through never-ceasing product launches and sustained technological developments. Acquisitions, partnerships, collaborations, and manufacturing expansions are also some of the business strategies taken up by the key players to drive revenue generation in the market. For example, in January 2022, Illumina, Inc. announced a partnership with SomaLogic to develop a product by integrating Illumina’s NGS technology with SomaScan Proteomics Assay. This partnership bolsters the rapidly growing high-throughput segment of the proteomics market.
Request a free sample copy or view the report summary: Molecular Biology Enzymes, Reagents, and Kits Market Report
By product, the kits and reagents held the largest share in 2024. The launch of new kits and reagents in response to the pandemic is one of the key reasons fueling the growth. Moreover, the repeated use of molecular biology kits and reagents in laboratory setups contributes to the growth
By application, sequencing accounted for the largest share in 2024 due to the introduction of single-cell sequencing and the leading presence of NGS. Use of NGS for analysis of genomics, tumor diagnostics, and biomarker discovery fuels the segment growth
By end-use, the pharma and biotech segment held the largest share in 2024. The presence of drug development pipelines, clinical trials, and continuous R&D activities require huge usage of molecular biology enzymes, kits, and reagents, thus leading to the segment growth
North America held the largest revenue share in 2024. This is attributed to the presence of numerous key pharmaceutical and biotechnology companies in the U.S. Furthermore, the prevalence of diseases in this region and increased use of molecular diagnostics contribute to revenue generation
Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market report based on product, application, end use, and region:
Molecular Biology Enzymes, Reagents And Kits Product Outlook (Revenue, USD Million, 2021 - 2033)
Kits & Reagents
PCR Kits
qPCR Kits
RT-PCR Kits
Library Preparation Kits
Cloning Kits
Purification Kits
Gene Editing Kits
Other Kits
Enzymes
Polymerases
DNA Polymerases
High Fidelity DNA Polymerases
Pfu DNA Polymerases
Phusion DNA Polymerases
Hot Start DNA Polymerases
Taq DNA Polymerases High Fidelity
Others
Thermostable DNA Polymerases
Standard Taq DNA Polymerases
Tth DNA Polymerases
Others
Strand-displacing DNA Polymerases
Bst DNA Polymerases
Phi29 DNA Polymerases
Others
RNA Polymerases
T7 RNA Polymerase
SP6 RNA Polymerase
T3 RNA Polymerase
Other RNA Polymerase
Reverse Transcriptase (RTs)
M-MLV RT
AMV RT
Thermostable RT
Template Switch
TGIRT
Induro
MarathonRT
Ligases
DNA Ligases
T4 DNA Ligases
E coli DNA Ligase
Taq DNA Ligase
Others
RNA Ligases
Nucleases
DNase I
RNase A, RNase H
Nickases
Restriction Nucleases
TdTs
Endonucleases
EndoQ
AP Nuclease
Kinases
Phosphatases
CRISPR-associated Enzymes
Cas9
Cas12a (Cpf1)
Cas13
Specialty Enzymes
Others
Molecular Biology Enzymes, Reagents And Kits Application Outlook (Revenue, USD Million, 2021 - 2033)
Cloning
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Sequencing
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
PCR
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Epigenetics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Genotyping
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RCA/MDA
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RNA Therapeutics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Transcriptomics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Proteomics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Liquid Biopsy
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Other Applications
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Molecular Biology Enzymes, Reagents And Kits End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Molecular Biology Enzymes, Reagents And Kits Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Molecular Biology Enzymes, Reagents And Kits Market
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN
Promega Corporation
New England Biolabs
Merck KGaA
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
Takara Bio, Inc.
LGC Limited
"The quality of research they have done for us has been excellent..."